Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) strains that express the mecA gene but are oxacillin susceptible (OS-MRSA; oxacillin MIC 2 mg/L) are increasingly reported. To gain molecular and functional insights on this observation, we focused on additional factors possibly contributing to phenotypic susceptibility.
Introduction
Oxacillin resistance in Staphylococcus aureus clinical isolates has been mostly attributed to the mecA gene that encodes the altered penicillin-binding protein 2a (PBP2a), with low affinity for b-lactams. PBP2a allows the completion of cell wall formation under b-lactam exposure, through transpeptidase reactions that cross-link peptidoglycan chains through pentaglycine bridges. Clinical strains that have an oxacillin MIC .2 mg/L or harbour the mecA gene are considered as methicillin-(oxacillin-) resistant S. aureus (MRSA) by the CLSI (formerly the NCCLS). 1 However, S. aureus strains that express a mecA gene may exhibit oxacillin MICs ranging from ,2 mg/L to .1000 mg/L and resistance phenotypes varying from extremely heterogeneous (frequencies of resistant colonies 10 27 or lower) to homogeneous. 2 -4 Although it is widely accepted that oxacillinsusceptible mecA-positive S. aureus (OS-MRSA) strains are usually heteroresistant and b-lactams might fail, 5 the additional factors that mediate different levels of heterogeneity still remain unknown and are probably very complex. 3 Phenotypically OS-MRSA are commonly detected in Greece; 6, 7 recently, we evaluated in vitro and in vivo oxacillin activity against such clinical isolates. 7 The existence of the mecA gene in oxacillin-susceptible strains has not been elucidated at the genomic and biochemical level. Earlier studies have underlined the important role of the enzymatic family FemXAB (factors essential for methicillin resistance) in the formation of the pentaglycine bridges that stabilize peptidoglycan chains in S. aureus. 8 It is also believed that fem genes, in addition to the mecA gene, are critical for the expression of homogeneous oxacillin resistance 9 and decreased expression of femA and femB genes leads to reduced methicillin resistance. 10 A question that may arise is whether mutations in the fem genes might exist in oxacillin-heteroresistant, mecA-positive, strains and confer the different levels of heteroresistance. 3, 5 It could be anticipated that non-heterogeneous, truly OS-MRSA strains with deficient cell wall biosynthesis may also exist. The aim of this study was to probe any existing mutations in the FemXAB enzymes that may affect their functional integrity and cell wall formation. We report herein the detection of specific amino acid shifts that might proportionally confer oxacillin susceptibility. To the best of our knowledge, there are no studies reporting specific fem gene mutations in clinical OS-MRSA strains.
Materials and methods

Bacterial strains
Four OS-MRSA clinical isolates (SA 1306, SA 1326, SA 1552 and SA 4666) against which oxacillin activity had previously been evaluated were studied. Oxacillin MICs ranged from 0.25 to 1 mg/L. All four isolates were susceptible to various non-b-lactam antibiotics. 7 These isolates belonged to two distinct types according to PFGE and to sequence type (ST)-728 (single-band variant type of ST-80). All isolates also carried SCCmec type IV. 7 By population analysis, the isolates SA 1326 and 4666 were truly oxacillin susceptible, while SA 1306 and 1552 were heteroresistant. 7 The isolate SA 6083 that belonged to the same ST, PFGE type and SCCmec type as the study isolates but exhibited an oxacillin MIC of 6 mg/L, the highly resistant isolate SA 2712 (MIC 256 mg/L) 7 and the susceptible mecAnegative S. aureus ATCC strain 29213 were used as controls.
Cloning and sequencing of genes and quantification of gene expression
The complete sequence of the mecA gene has been determined previously. 7 The expression of the mecA and fem genes was quantified by real-time RT-PCR (qRT-PCR), according to current protocols. 11 The primers used for the mecA gene were those described previously 7 and those for the fem genes were as follows: femX, femXFWD and arc-R 5 0 -AGGTATCTGCTTCAATCAGCG-3 0 ; control reactions of untranscribed RNA were also included. PCRs were performed using Phusion DNA polymerase (Finnzymes, Espoo, Finland) and PCR products were cloned in pSC-A vector (Stratagene) and sequenced in duplicate (Macrogen, Seoul, South Korea). Data were analysed using Chromas v.1.45 and MEGAv.3.1 software.
Genomic analysis and molecular modelling of FemXAB proteins
The sequences of mecA, femX, femA and femB genes and the corresponding proteins of strain MRSA252 (GenBank accession number BX571856) and of all known MRSA genomes were obtained from available public databases (www.tigr.org). It should be noted that mecA and fem genes are highly conserved exhibiting only a few differences from each other in the MRSA genomes that we compared. To evaluate only mutations that could have clinical significance, we focused on detected mutations in positions that differ in comparison with all known MRSA genomes and affect the enzyme structure through amino acid substitutions. The sequences of mecA, femX, femA and femB genes of the study strains and for comparison those of strain MRSA252 were aligned with Clustal W. These alterations were imported to the sequence of the corresponding protein from MRSA252. The new sequence containing all the observed mutations for each Fem factor was used for tertiary structure prediction using the web-based automated comparative protein modelling server SWISS-MODEL (swissmodel.expasy.org), based on protein structure homology modelling. 12 The known S. aureus FemA crystal structure (PDB code: 1rlz) was used as the template structure for determination of FemB and FemX comparative homology models. 12 The altered amino acids are indicated as atoms and the rest of the molecule as ribbons, using UCSF Chimera v.1 software. The structures derived from molecular modelling were compared with the known crystal structure from S. aureus FemA 13 and the structure model that has been reported for Weissella viridescens FemX. 14 
Growth curves of bacterial isolates
Growth curves were determined by diluting 0.1 mL of overnight MuellerHinton broth culture of the OS-MRSA strains, as well as the low-level oxacillin-resistant SA 6083 and the highly resistant SA 2712 control isolates, in 15 mL of broth followed by incubation at 378C under constant shaking. The optical density of a 1 mL aliquot of each broth culture was determined at each hour for the first 10 h.
Results
qRT-PCR assays
qRT -PCR for the mecA gene showed comparable expression levels in the four OS-MRSA strains and the low-and high-level MRSA control strains. In addition, qRT-PCR for the fem gene family showed no significant variations in the expression levels of femX, femA and femB genes between the study and control strains ( Figure 1 ). Dissociation curves and agarose gel electrophoresis showed a single product in all cases. Therefore, we concluded that the corresponding enzymes that are responsible for the synthesis of pentaglycine bridges should be present in the study isolates.
Detection of mutations and alignments
PCR amplicons of the four OS-MRSA isolates and the low-level MRSA SA 6083 for all genes under study were cloned in the pSC-A vector and sequenced. The mecA gene, which was tested previously, did not have any mutations. 7 Several mutations for the femX, femA and femB genes were detected, compared with the respective genes of MRSA252. As shown in Figure 2 , when we performed multiple alignments, several amino acid substitutions were accumulated for every Fem factor. More specifically, the mutations that were detected in total were as follows: FemX, K32R, H11N, N18H, S184F, S263F and S305F; for FemA, N182T, D210N, A216T, E234D, E247V, K301R, Q346P, Y361F, I398F or G, N402K and V415L; and Mutations in Fem proteins of OS-MRSA 627 JAC FemB, G191D, K221E, Y233C, G234K, L238I, N324Y, H344N, I388V and L410F. The truly oxacillin-susceptible isolate SA 1326 had 6 mutations for FemX, 6 for FemA and 0 for FemB (total 12) and the SA 4666 had 6 mutations for FemX, 4 for FemA and 4 for FemB (total 14). The oxacillin heteroresistant isolate SA 1306 had 4 mutations for FemX, 1 for FemB and 5 for FemA (total 10) and SA 1552 had 4 mutations for FemX, 3 for FemA and 2 for FemB (total 9). Interestingly, the low-level resistant isolate SA 6083, which belonged to the same ST, PFGE type and SCCmec type as the study isolates, had only three mutations (one for FemX, two for FemA and none for FemB) (Figure 2) .
According to the pairwise distance calculations generated by the Mega software for FemX protein, the maximum distance between the homologues of the above available MRSA genomes is 0.007. Interestingly, FemX proteins of the truly OS-MRSA (SA 1326 and 4666) exhibit a maximum distance of 0.014, while those of the heteroresistant SA 1306 and 1552 a distance of 0.010. For FemA, the strains SA 1326 and 4666 also exhibit a maximum distance of 0.014 compared with the respective factors from MRSA genomes. Finally, FemB proteins exhibit fewer differences and the maximum distances are exhibited by isolates SA 1306 and 4666. Thus, from an evolutionary point of view it appears that the increasing sensitivity of the clinical strains correlates with the increasing distance between the mutated Fem factors and their counterparts in the known MRSA genomes.
In silico analysis and position of mutations in the predicted structures Considering the importance of FemXAB factors for cell viability and oxacillin susceptibility, we examined the positioning of these mutations at the structural level to predict whether they could confer a structural and functional deficiency of Fem factors in these strains. Based on the known crystal structure of S. aureus FemA 13 and based on the strong conservation of Fem factors among the MRSA genomes that are available so far, we performed in silico analysis of all three factors to evaluate the possible effect of the detected mutations. Based on the available web-based algorithms, the models generated are in good agreement with the structural models derived from X-ray crystallographic studies (Figure 3) . Although the crystal structure of W. viridescens FemX and the docking model of W. viridescens FemX-tRNA Ala14 were also reported, we excluded them from our initial modelling attempts, because of the low homology with S. aureus FemX and because W. viridescens FemX utilizes different substrates from the S. aureus Fem factors. However, all the available structural data were considered in comparison with our analysis.
The models that are presented in Figure 3 show that all S. aureus Fem factors must have a similar structure because of the high conservation of their primary structures. The main difference between S. aureus FemX and W. viridescens FemX is a coiled-coil domain that is similar to the same domain initially found in bacterial seryl-tRNA synthetases and that acts as a molecular 'switch' that flips to hold the tRNA substrates. However, the overall structures appear to be very similar. Comparison between S. aureus FemA (Figure 3) and the homology models that we produced shows that the majority of mutations are accumulated in the L-shaped channel in the core of the protein molecule that both bears the binding activity for the hexapeptide lipid substrate and encompasses residues interacting with the Gly-tRNA Gly substrates serving as glycine donors for pentaglycine bridge synthesis. In addition, mutations that were detected in the coiled-coil region of FemX and FemA proteins could affect the role of this domain in the binding and stabilization of tRNA substrates in the active site. It should be noted that most of the mutations shown in Figure 2 involve significant changes of important amino acids, such as S184F, S263F and S305F in FemX. Given the essential nature of the amino acid substitutions in a region that directly affects the binding and recognition capacity of all Fem factors for the lipid chain and the tRNA substrates and the enzyme activity, we assume that accumulation of such mutations could possibly affect intact cell wall synthesis. Therefore, it could contribute to the oxacillin susceptibility that these clinical isolates exhibit, although the mecA gene exists and is expressed similarly in all strains tested.
Growth curve analysis showed that the OS-MRSA, the lowand high-level oxacillin-resistant MRSA isolates had similar growth rates (data not shown). This observation indicates that the mutations in the FemXAB proteins of the OS-MRSA isolates did not result in a significant reduction in their viability.
Discussion
S. aureus clinical isolates carrying mecA that are phenotypically oxacillin susceptible have been reported to be increasing recently. 2,5 -7 In this context, different additional factors such as the Fem factors, which are considered as important or essential (FemX) for cell viability, may be involved 15 and lead to a global transcriptional rearrangement in S. aureus that might include oxacillin responsiveness. Our in vitro and in silico analyses suggest that the apparent oxacillin susceptibility could be Giannouli et al. Mutations in Fem proteins of OS-MRSA attributed to accumulated mutations in the Fem proteins. This is further supported by the observation that the low-level MRSA control SA 6083, which was very similar to the OS-MRSA study isolates, differing only by a higher oxacillin MIC, had considerably fewer mutations in the FemXAB proteins.
In an effort to extract information on the possible impact of the newly identified mutations, we performed homology modelling of FemX, FemA and FemB enzymes. This in silico analysis was primarily based on the S. aureus FemA crystal structure and was compared with the crystal structure from W. viridescens FemX. The available biochemical reports and analysis showed that all Fem factors are highly similar in their tertiary structure, the only major difference being located in the coiled-coil domain of all S. aureus Fem factors; the presence or absence of this region is used to classify Fem factors and their homologues.
The majority of the FemA factor mutations from the clinical strains of S. aureus were positioned in the 1B region (positions 210, 216, 234, 346, 361). This region is crucial for FemA enzymatic activity, forming an L-shaped channel, which is dedicated to serve as the binding cavity for the hexapeptide lipid substrate. Moreover, the only break in the main chain electron density is located over the top of this channel and corresponds to residues 209-220. These 12 residues may be responsible for trapping the disaccharide hexapeptide lipid substrate in the channel, as they could close down over the channel and then re-open after glycine addition. Interestingly, the FemA factor of the most oxacillin-susceptible clinical strain (SA 1326) harbours two mutations in this 'hinge' region (D210N and A216T), which may alter the region's functionality.
In the case of FemB factor, eight out of nine amino acid alterations observed in the study isolates are positioned in the region that corresponds to 1B of FemA. In both FemA and FemB factors mutations are also present in different domains that are not associated with a specific function. However, there are regions that may be responsible for the possible interactions between these factors, although they are not yet specified.
Finally, FemX factors possess mutations in positions that are not included in the already functionally characterized domains. The only possible critical mutation that could affect directly the function of FemX is S263F, which is located in the coiled-coil domain and may alter the interaction with the glycylated tRNA Gly substrate. Interestingly, the FemX factors from the two truly oxacillin-susceptible strains harbour conserved mutations in positions 263 and 305. These mutations probably reduce FemX activity to a degree that could allow the formation of an at least minimal percentage of peptidoglycan, since its total inhibition is lethal. However, future in-depth biochemical analysis of all the mutations detected will reveal the exact contribution of each mutation to this paradoxical phenomenon both in vitro and in vivo. Nevertheless, the similar growth kinetics of the OS-MRSA isolates, compared with the MRSA controls, suggest that the increased susceptibility of these isolates not only to oxacillin but also to many other antimicrobial classes was not due to reduced fitness resulting from FemXAB mutations.
Whatever the underlying reasons, it is evident from our report that mecA expression is not an absolute determinant of oxacillin resistance. Efforts to elucidate the causes of heteroresistance should be expanded to detection and characterization of new molecular targets, possibly associated with the atypical susceptibility of several nosocomial 'MRSA'. It is evident that any factor playing a role in cell wall synthesis and assembly could represent a putative additional genetic factor contributing to the OS-MRSA phenotype. In this context, we are currently investigating possible auxiliary genetic factors that could contribute to the oxacillin resistance phenotype in a larger collection of OS-MRSA strains.
Nucleotide sequence accession numbers
The GenBank accession numbers of the nucleotide sequences reported here for fem genes of the study strains that exhibit nucleotide differences from the respective genes of MRSA252 are as follows: (i) SA 1306: femA, GQ284640; femB, GQ284648; femX, GQ284650; (ii) SA 1326: femA, GQ284641; femX, GQ284651; (iii) SA 1552: femA, GQ284643; femB, GQ284649; femX, GQ284652; (iv) SA 4666: femA, GQ284642; femB, GQ284645; femX, GQ284653; (v) SA 6083: femA, GQ284644; femX, GQ284654.
